Skip main navigation

Research & Development
Research & Development

Home > R&D > Licensing Activities > Out Licensing

Skip side navigation

Main contents starts here

Out Licensing

If we judge that a partner with excellent know-how can more effectively handle the matter depending on the target disease area or compound, we may select out-licensing on research, development, and/or sales of our own compounds by alliance without adhering to independent drug development by ourselves to provide excellent drugs to patients and medical service providers as early as possible.


Licensee Product Name or Development Code Drug Class Territory Time
Indication(s)
Tobira TAK-220/TAK-652 CCR5 Antagonists World Aug.07
HIV Infection

Page Top